3 Apr 2026
Abstract 7866: BMI- and subtype-specific molecular clusters reveal distinct obesity mechanisms in breast cancer across Nigerian and U.S. cohorts.Publisher siteCancer Research, Cancer Risks and Factors
Active, last published 2026
1
H-index
1
Citations
Adetola has not officially claimed their profile. If you are Adetola, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Adetola Daramola will appear here once their profile is updated.
02 · Reach
Publication output and reach
Adetola's work has been cited 1 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchLagos University Teaching Hospital, NigeriaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works3 Apr 2026
Abstract 6263: Association of tumor infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: Analysis of the MEND study.Publisher siteCancer Research, Inflammatory Biomarkers in Disease Prognosis
16 Feb 2026Open access1cites
Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trialPublisher siteThe Lancet Global Health, Hemoglobinopathies and Related Disorders
21 Apr 2025
Abstract 7360: Characterizing the immune microenvironment of Nigerian breast tumors by subtypePublisher siteCancer Research, Cancer Immunotherapy and Biomarkers
1 Jan 2024Open access
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Taxotere and Trastuzumab in Nigerian Women with Her2-Positive Breast Cancer (ARETTA): First Report from the Nigerian Breast Cancer Study GroupPublisher siteSSRN Electronic Journal, Breast Cancer Treatment Studies
1 Mar 2023
Abstract OT2-21-01: Assessing Response to neoadjuvant Taxotere and TrAstuzumab in Nigerian women with HER2-positive breast cancer (ARETTA)Publisher siteCancer Research, Breast Cancer Treatment Studies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Adetola?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you